(2S)-6-amino-2-[[(2R)-2-[[[[(2S)-2-[[(2R)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]propanoyl]amino]-[(4-hydroxyphenyl)methyl]carbamoyl]amino]-3-phenylpropanoyl]amino]hexanamide

ID: ALA2163484

Max Phase: Preclinical

Molecular Formula: C43H54N12O7

Molecular Weight: 850.98

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)NN(Cc1ccc(O)cc1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O

Standard InChI:  InChI=1S/C43H54N12O7/c1-26(50-41(60)37(20-29-22-48-34-12-6-5-11-32(29)34)52-40(59)33(45)21-30-23-47-25-49-30)39(58)54-55(24-28-14-16-31(56)17-15-28)43(62)53-36(19-27-9-3-2-4-10-27)42(61)51-35(38(46)57)13-7-8-18-44/h2-6,9-12,14-17,22-23,25-26,33,35-37,48,56H,7-8,13,18-21,24,44-45H2,1H3,(H2,46,57)(H,47,49)(H,50,60)(H,51,61)(H,52,59)(H,53,62)(H,54,58)/t26-,33-,35-,36+,37+/m0/s1

Standard InChI Key:  ULBKJPIZMQDQBL-MHKQCRJVSA-N

Associated Targets(Human)

GHSR Tclin Ghrelin receptor (6229 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cd36 Platelet glycoprotein 4 (161 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cd36 Platelet glycoprotein 4 (181 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aorta (52 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 850.98Molecular Weight (Monoisotopic): 850.4238AlogP: 0.65#Rotatable Bonds: 21
Polar Surface Area: 308.57Molecular Species: BASEHBA: 10HBD: 11
#RO5 Violations: 2HBA (Lipinski): 19HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.36CX Basic pKa: 9.96CX LogP: -1.24CX LogD: -3.28
Aromatic Rings: 5Heavy Atoms: 62QED Weighted: 0.04Np Likeness Score: -0.04

References

1. Proulx C, Picard É, Boeglin D, Pohankova P, Chemtob S, Ong H, Lubell WD..  (2012)  Azapeptide analogues of the growth hormone releasing peptide 6 as cluster of differentiation 36 receptor ligands with reduced affinity for the growth hormone secretagogue receptor 1a.,  55  (14): [PMID:22712585] [10.1021/jm300557t]
2. Chignen Possi K, Mulumba M, Omri S, Garcia-Ramos Y, Tahiri H, Chemtob S, Ong H, Lubell WD..  (2017)  Influences of Histidine-1 and Azaphenylalanine-4 on the Affinity, Anti-inflammatory, and Antiangiogenic Activities of Azapeptide Cluster of Differentiation 36 Receptor Modulators.,  60  (22): [PMID:29028172] [10.1021/acs.jmedchem.7b01209]
3.  (2018)  Novel cyclic peptides and uses thereof, 
4.  (2013)  Azapeptides as cd36 binding compounds,